Home/Filings/4/0001304492-24-000028
4//SEC Filing

Guttman-McCabe Christopher 4

Accession 0001304492-24-000028

CIK 0001304492other

Filed

Feb 29, 7:00 PM ET

Accepted

Mar 1, 9:27 PM ET

Size

5.8 KB

Accession

0001304492-24-000028

Insider Transaction Report

Form 4
Period: 2024-02-28
Guttman-McCabe Christopher
Chief Reg & Comm Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-02-28+60,00060,000 total
    Exercise: $37.42Exp: 2034-02-28Common Stock (60,000 underlying)
Footnotes (1)
  • [F1]8,000 of the option shares vest and become exercisable on May 22, 2024; 32,000 additional option shares vest and become exercisable on May 22, 2025; and the remaining 20,000 unvested option shares vest and become exercisable on May 22, 2026.

Issuer

Anterix Inc.

CIK 0001304492

Entity typeother

Related Parties

1
  • filerCIK 0001828490

Filing Metadata

Form type
4
Filed
Feb 29, 7:00 PM ET
Accepted
Mar 1, 9:27 PM ET
Size
5.8 KB